Ignite Creation Date:
2025-12-24 @ 11:50 PM
Ignite Modification Date:
2026-02-28 @ 7:29 AM
Study NCT ID:
NCT02548351
Status:
TERMINATED
Last Update Posted:
2024-10-01
First Post:
2015-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Sponsor:
Intercept Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2015-09-01
First Submit QC Date:
None
Study First Post Date:
2015-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-08-14
Results First Submit QC Date:
None
Results First Post Date:
2024-09-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-05
Last Update Post Date:
2024-10-01
Last Update Post Date Type:
ACTUAL